Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [74]
News [51]
Articles [25]
Editorials [8]
Conferences [0]
elearning [0]
Choosing the control arm/standard of care in clinical trials
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Choosing the control arm/standard of care in clinical trials ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
27 Oct 2022
Impact of the Choosing Wisely conference in Nepal
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Impact of the Choosing Wisely conference in Nepal ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
7 Oct 2022
How to read a Meta-analysis?
Dr Bishal Gyawali - Queen's University, Kingston, Canada
How to read a Meta-analysis? ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
25 Sep 2022
Pitfalls in interpretation of clinical trials
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Pitfalls in interpretation of clinical trials ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
25 Sep 2022
Defining value based care for LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Defining value based care for LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
18 Sep 2022
Choosing the control arm/standard of care in clinical trials
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Choosing the control arm/standard of care in clinical trials ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
18 Sep 2022
ESMO 2022: Breast and ovarian trial analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Breast and ovarian trial analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
14 Sep 2022
ESMO 2022: Highlights, commentary and analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Highlights, commentary and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
12 Sep 2022
Low-dose nivolumab leads to improved overall survival for head and neck cancer...
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Low-dose nivolumab leads to improved overall survival for head and neck cancer patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022
Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022
Lack of access to new cancer medicines in LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Lack of access to new cancer medicines in LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
11 Jun 2022
Comment: LUMINA results show that women with low levels of the Ki67 biomarker...
Dr Corey Wayne Speers - University of Michigan, Ann Arbor, USA
Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy ( Dr Corey Wayne Speers - University of Michigan, Ann Arbor, USA )
9 Jun 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation